These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11858352)
1. Bisphosphonates in bone diseases other than osteoporosis. Orcel P; Beaudreuil J Joint Bone Spine; 2002 Jan; 69(1):19-27. PubMed ID: 11858352 [TBL] [Abstract][Full Text] [Related]
2. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis]. Chapurlat R; Meunier PJ Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126 [TBL] [Abstract][Full Text] [Related]
3. Treatment of bone diseases with bisphosphonates, excluding osteoporosis. Devogelaer JP Curr Opin Rheumatol; 2000 Jul; 12(4):331-5. PubMed ID: 10910187 [TBL] [Abstract][Full Text] [Related]
4. [Bisphosphonates: indications in bone diseases other than osteoporosis]. Abdelmoula LC; Ben M'barek R; Ben Hadj Yahia C; Tekaya R; Testouri N; Chaabouni L; Zouari R Tunis Med; 2011 Jun; 89(6):511-6. PubMed ID: 21681711 [TBL] [Abstract][Full Text] [Related]
5. Alternative use of bisphosphonate therapy for rheumatic disease. Le Goff B; Berthelot JM; Maugars Y; Romas E Curr Pharm Des; 2010; 16(27):3045-52. PubMed ID: 20722620 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate use in conditions other than osteoporosis. Silverman SL Ann N Y Acad Sci; 2011 Feb; 1218():33-7. PubMed ID: 20946575 [TBL] [Abstract][Full Text] [Related]
7. [Calcitonin and somatic pain: study of the mechanism of the antalgic action of the hormone in osteoarthrosis]. Chiarini P; Fini MT; Matassi L Clin Ter; 1979 May; 89(4):405-17. PubMed ID: 535320 [No Abstract] [Full Text] [Related]
8. Bisphosphonates for Paget's disease of bone in adults. Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423 [TBL] [Abstract][Full Text] [Related]
10. Treatment of patients with Paget's disease of bone. Roux C; Dougados M Drugs; 1999 Nov; 58(5):823-30. PubMed ID: 10595863 [TBL] [Abstract][Full Text] [Related]
11. Calcitonin or diphosphonates for osteolytic Paget's disease? Nagant de Deuxchaisnes C; Rombouts-Lindemans C; Huaux JP; Devogelaer JP; Malghem J; Maldague B Lancet; 1980 Feb; 1(8164):374. PubMed ID: 6101833 [No Abstract] [Full Text] [Related]
12. Bisphosphonates in the treatment of malignant bone disease. Berenson JR; Lipton A Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275 [TBL] [Abstract][Full Text] [Related]
13. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. Abelson A Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324 [TBL] [Abstract][Full Text] [Related]
14. [Clinical and therapeutic studies of synthetic salmon calcitonin in some osteopathies]. Torrioli E; Citti C; Picchi L Clin Ter; 1982 Jul; 102(2):123-9. PubMed ID: 6183044 [No Abstract] [Full Text] [Related]
15. [Questions and answers about bisphosphonates]. Letonturier P Presse Med; 2007 Mar; 36(3 Pt 1):440. PubMed ID: 17436449 [No Abstract] [Full Text] [Related]
16. [Bisphosphonates in pharmacotherapy of bone diseases]. Iur'ieva EA; Matkovskaia TA; Elagina IA; Stoliarov IuIu Eksp Klin Farmakol; 2000; 63(3):74-9. PubMed ID: 10934603 [TBL] [Abstract][Full Text] [Related]
17. Modern therapy for Paget's disease of bone: focus on bisphosphonates. Devogelaer JP Treat Endocrinol; 2002; 1(4):241-57. PubMed ID: 15799218 [TBL] [Abstract][Full Text] [Related]
18. Management of Paget's disease of bone. Langston AL; Ralston SH Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244 [TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates in the treatment of disorders of mineral metabolism. Singer FR; Minoofar PN Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099 [TBL] [Abstract][Full Text] [Related]